ROSELLA: A phase 3 study of relacorilant in combination with nab-paclitaxel versus investigator's choice in advanced, platinum-resistant, high-grade epithelial ovarian, primary peritoneal, or fallopian-tube cancer.

被引：0
|
作者：
Olawaiye, Alexander
Monk, Bradley J.
Herzog, Thomas J.
Copeland, Larry J.
Coleman, Robert L.
Moore, Kathleen N.
Randall, Leslie M.
Slomovitz, Brian M.
O'Malley, David M.
Eskander, Ramez Nassef
Pothuri, Bhavana
Van Gorp, Toon
Pignata, Sandro
Nicum, Shibani
Tudor, Iulia Cristina
Nguyen, Dorothy D.
Lorusso, Domenica
机构：
[1] Univ Pittsburgh, Pittsburgh, PA USA
[2] Creighton Univ Sch Med, Univ Arizona Coll Med, GOG Fdn, Phoenix, AZ USA
[3] Univ Cincinnati Canc Inst, Cincinnati, OH USA
[4] Ohio State Univ, James Canc Ctr, Columbus, OH USA
[5] US Oncol Res, Spring, TX USA
[6] Univ Oklahoma HSC, Stephenson Canc Ctr, Oklahoma City, OK USA
[7] Virginia Commonwealth Univ, Massey Canc Ctr, Richmond, VA USA
[8] Florida Int Univ, Mt Sinai Med Ctr, Miami Beach, FL USA
[9] Ohio State Univ, James Comprehens Canc Ctr, Columbus, OH USA
[10] Moores Canc Ctr, La Jolla, CA USA
[11] NYU Grossman Sch Med, Perlmutter Canc Ctr, NYU Langone Hlth, Ney York, NY USA
[12] Univ Hosp Leuven, Leuven Canc Inst, Leuven, Belgium
[13] Ist Nazl Tumori Napoli, Naples, Italy
[14] Univ Coll London Canc Inst, London, England
[15] Corcept Therapeut, Menlo Pk, CA USA
[16] Catholic Univ, IRCCS, Sacred Heart & Fondazione Policlinico Gemelli, Rome, Italy
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2022年 / 40卷 / 16期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
TPS5620
引用
收藏
页数：1
相关论文
共 50 条
  • [1] Clinical Trial Protocol for ROSELLA: a phase 3 study of relacorilant in combination with nab-paclitaxel versus nab-paclitaxel monotherapy in advanced platinum-resistant ovarian cancer
    Olawaiye, Alexander B.
    Kim, Jae-Weon
    Bagameri, Andrea
    Bishop, Erin
    Chudecka-Glaz, Anita
    Devaux, Alix
    Gladieff, Laurence
    Gordinier, Mary E.
    Korach, Jacob
    McCollum, Michael E.
    Mileshkin, Linda
    Monk, Bradley J.
    Nicum, Shibani
    Nogueira-Rodrigues, Angelica
    Oaknin, Ana
    O'Malley, David M.
    Orlando, Mauro
    Dreiling, Lyndah
    Tudor, Julia C.
    Lorusso, Domenica
    JOURNAL OF GYNECOLOGIC ONCOLOGY, 2024, 35 (04)
  • [2] ROSELLA - GOG-3073-ENGOT-OV72/MITO: A phase 3 study of relacorilant plus nab-paclitaxel vs. nab-paclitaxel in advanced, platinum-resistant ovarian cancer
    Olawaiye, Alexander
    Van Gorp, Toon
    Monk, Bradley
    Novak, Zoltan
    O'Malley, David
    Oaknin, Ana
    Herzog, Thomas
    Gladieff, Laurence
    Alvarez, Edwin
    Korach, Jacob
    Chan, John
    Nicum, Shibani
    Bishop, Erin
    Chudecka-Glaz, Anita
    Covens, Allan
    Muller, Carolyn
    Westhoff, Gina
    Fishman, David
    Dreiling, Lyndah
    Pashova, Hristina
    Tudor, Iulia Cristina
    Lorusso, Domenica
    GYNECOLOGIC ONCOLOGY, 2023, 176 : S153 - S154
  • [3] ROSELLA (GOG-3073, ENGOT-OV72/MITO): A PHASE 3 STUDY OF RELACORILANT plus NAB-PACLITAXEL VS. NAB-PACLITAXEL IN ADVANCED, PLATINUM-RESISTANT OVARIAN CANCER
    Lorusso, Domenica
    Bagameri, Andrea
    Bishop, Erin
    Chudecka-Glaz, Anita
    Devaux, Alix
    Gladieff, Laurence
    Gordinier, Mary E.
    Kim, Jae-Weon
    Korach, Jacob
    Mccollum, Michael E.
    Mileshkin, Linda
    Monk, Bradley J.
    Nicum, Shibani
    Nogueira-Rodrigues, Angelica
    Oaknin, Ana
    O'Malley, David
    Orlando, Mauro
    Dreiling, Lyndah
    Tudor, Iulia Cristina
    Olawaiye, Alexander B.
    INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER, 2023, 33 : A411 - A412
  • [4] Rosella (GOG-3073, ENGOT-OV72/MITO): a phase 3 study of relacorilant plus nab paclitaxel vs. nab-paclitaxel in platinum-resistant ovarian cancer
    Lorusso, Domenica
    Bagameri, Andrea
    Bishop, Erin
    Chudecka-Glaz, Anita
    Devaux, Alix
    Gladieff, Laurence
    Gordinier, Mary
    Kim, Jae-Weon
    Korach, Jacob
    Mccollum, Michael
    Mileshkin, Linda
    Monk, Bradley
    Nicum, Shibani
    Nogueira-Rodrigues, Angelica
    Oaknin, Ana
    O'Malley, David
    Orlando, Mauro
    Dreiling, Lyndah
    Tudor, Iulia Cristina
    Olawaiye, Alexander
    INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER, 2023, 33 (SUPPL_4) : A255 - A255
  • [5] A phase II study of bevacizumab with nab-paclitaxel in patients with recurrent, platinum-resistant primary epithelial ovarian or primary peritoneal carcinoma
    Tillmanns, T. D.
    Lowe, M. P.
    Schwartzberg, L. S.
    Walker, M. S.
    Stepanski, E. J.
    JOURNAL OF CLINICAL ONCOLOGY, 2010, 28 (15)
  • [6] A phase II evaluation of nab-paclitaxel in the treatment of recurrent or persistent platinum-resistant ovarian, fallopian tube, or primary peritoneal cancer: A Gynecologic Oncology Group (GOG) study
    Coleman, R. L.
    Brady, W.
    McMeekin, D. S.
    Rose, P. G.
    Soper, J. T.
    Lentz, S. S.
    Hoffman, J. S.
    Shahin, M. S.
    JOURNAL OF CLINICAL ONCOLOGY, 2010, 28 (15)
  • [7] Phase Ib Study of Navicixizumab Plus Paclitaxel in Patients With Platinum-Resistant Ovarian, Primary Peritoneal, or Fallopian Tube Cancer
    Fu, Siqing
    Corr, Bradley R.
    Culm-Merdek, Kerry
    Mockbee, Colleen
    Youssoufian, Hagop
    Stagg, Robert
    Naumann, R. Wendel
    Wenham, Robert M.
    Rosengarten, Rafael D.
    Benjamin, Laura
    Hamilton, Erika Paige
    Moore, Kathleen N.
    JOURNAL OF CLINICAL ONCOLOGY, 2022, 40 (23) : 2568 - +
  • [8] A phase Ib dose-escalation study of binimetinib (MEK162) in combination with weekly paclitaxel in patients with platinum-resistant epithelial ovarian, fallopian tube or primary peritoneal cancer.
    Grisham, Rachel N.
    Gordon, Michael S.
    Harb, Wael A.
    Aghajanian, Carol
    McMeekin, D. Scott
    McKinley, Kristin
    Anderson, Lisa Renee
    Chavira, Renae
    Christy-Bittel, Janna
    Barrett, Emma
    Moore, Kathleen N.
    JOURNAL OF CLINICAL ONCOLOGY, 2015, 33 (15)
  • [9] ARTISTRY-7: A phase 3, multicenter study of nemvaleukin alfa in combination with pembrolizumab versus chemotherapy in patients (pts) with platinum-resistant epithelial ovarian, fallopian tube, or primary peritoneal cancer.
    Herzog, Thomas J.
    Moore, Kathleen N.
    Konstantinopoulos, Panagiotis A.
    Gilbert, Lucy
    Hays, John L.
    Monk, Bradley J.
    O'Malley, David M.
    Sehouli, Jalid
    Barlin, Joyce N.
    Graham, Julie R.
    Md, Monali Desai
    Wang, Yan
    Du, Yangchun
    Dalal, Rita P.
    Coleman, Robert L.
    JOURNAL OF CLINICAL ONCOLOGY, 2022, 40 (16)
  • [10] A phase II trial of weekly nab-paclitaxel with GM-CSF as chemoimmunotherapy for platinum-resistant epithelial ovarian cancer.
    Swensen, R. E.
    Childs, J.
    Higgins, D.
    Gooley, T.
    Goff, B. A.
    Fintak, P. A.
    Buening, B.
    Disis, M. L.
    JOURNAL OF CLINICAL ONCOLOGY, 2011, 29 (15)
12345